Dr. Zvi Perry | Breast Surgery | Best Researcher Award

Soroka University Medical Center | Israel

AUTHOR PROFILE

Scopus

ORCID ID

Google Scholar

DR. ZVI PERRY, SOROKA UNIVERSITY MEDICAL CENTER, MRI AND BREAST SURGERY, ISRAEL

🎓EARLY ACADEMIC PURSUITS

Dr. Zvi Perry began his academic journey with a solid foundation in medicine, specializing in surgical disciplines. He pursued his medical education in Israel, where he demonstrated an early interest in the field of breast surgery. His commitment to learning and research was evident from the start, leading him to focus on innovative approaches in breast surgery and medical imaging, particularly in the use of MRI technology for diagnosis and treatment planning.

💼PROFESSIONAL ENDEAVORS

Dr. Perry’s professional career is marked by his significant contributions to Soroka University Medical Center, where he has served as a leading figure in the Department of Surgery. His expertise in breast surgery has been a cornerstone of his work, and he has been instrumental in integrating advanced MRI techniques into surgical practices. His dedication to patient care and surgical precision has earned him a reputation as one of Israel’s foremost breast surgeons.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON BREAST SURGERY

Dr. Perry’s research focuses on the intersection of breast surgery and MRI technology. He has conducted pioneering studies on the use of MRI in the early detection and treatment of breast cancer, enhancing the accuracy of surgical interventions. His research has contributed to the development of less invasive surgical techniques, improving outcomes for patients. Dr. Perry’s work also extends to the study of post-surgical recovery and the long-term effects of breast surgery on patients’ quality of life.

🌍IMPACT AND INFLUENCE

Dr. Perry’s influence extends beyond the walls of Soroka University Medical Center. He has been an active participant in national and international conferences, where he has shared his insights on breast surgery and MRI applications. His work has influenced surgical practices in Israel and around the world, contributing to the global advancement of breast cancer treatment. Dr. Perry is also involved in mentoring young surgeons, passing on his knowledge and skills to the next generation.

📚ACADEMIC CITES AND PUBLICATIONS

Dr. Perry has published extensively in leading medical journals, with numerous articles cited by his peers in the fields of breast surgery and medical imaging. His work is frequently referenced in studies related to breast cancer diagnosis, MRI applications, and surgical innovations. These citations underscore the importance of his contributions to the medical community and highlight his role as a thought leader in his field.

🌟LEGACY AND FUTURE CONTRIBUTIONS

Dr. Perry’s legacy is defined by his commitment to improving breast cancer treatment through surgical excellence and innovative research. His ongoing work in MRI technology continues to push the boundaries of what is possible in breast surgery. As he looks to the future, Dr. Perry is focused on further refining surgical techniques and expanding the use of MRI in other areas of surgery. His contributions will undoubtedly continue to shape the future of breast cancer treatment, leaving a lasting impact on both patients and the medical community.

💡OTHER IMPORTANT TOPICS

In addition to his primary research and clinical work, Dr. Perry is also involved in educational initiatives aimed at raising awareness about breast cancer and the importance of early detection. He collaborates with various organizations to promote health education and support breast cancer patients throughout their treatment journey. Dr. Perry’s holistic approach to medicine, combining cutting-edge technology with compassionate care, exemplifies his dedication to advancing healthcare in Israel and beyond.

🎯CONCLUSION

Dr. Zvi Perry’s career at Soroka University Medical Center is a testament to his unwavering dedication to advancing breast surgery through the innovative use of MRI technology. His early academic pursuits laid a strong foundation for a professional journey marked by groundbreaking research, impactful contributions, and a deep commitment to patient care. Dr. Perry’s influence extends globally, with his work shaping the future of breast cancer treatment and surgical practices. As a mentor, researcher, and surgeon, his legacy is one of excellence and innovation, ensuring that his contributions will continue to benefit the medical community and patients for years to come. 🌟

📊🔬NOTABLE PUBLICATION:

- Title: Laparoscopic Sleeve Gastrectomy Following Failed Laparoscopic Adjustable Gastric Banding—a Comparison Between One- and Two-Stage Procedures, an Israeli National Database Study
  Authors: Perry, Z., Romano-Zelekha, O., Sakran, N., Netz, U., Kirshtein, B.
  Journal: Obesity Surgery
  Year: 2021

- Title: Circulating Cell-free DNA in Patients with Acute Biliary Pancreatitis: Association with Disease Markers and Prolonged Hospitalization Time A Prospective Cohort Study
  Authors: Gibor, U., Perry, Z., Netz, U., Sebbag, G., Douvdevani, A.
  Journal: Annals of Surgery
  Year: 2022

- Title: A Comparison of One- and Two-Stage Laparoscopic Sleeve Gastrectomy Following Failed Laparoscopic Adjustable Gastric Banding Using the BAROS Score
  Authors: Perry, Z.H., Zioni, T., Netz, U., Chorny, A., Kirshtein, B.
  Journal: Obesity Surgery
  Year: 2022

- Title: Banded One-Anastomosis Gastric Bypass (BOAGB) for Patients Living with Obesity and Extreme Obesity: A Single Institution’s Experience
  Authors: Quint, E., Perry, Z.H., Elkrinawi, N., Sebbag, G., Dukhno, O.
  Journal: Obesity Surgery
  Year: 2024

- Title: Gender Comparisons of Surgical Outcomes in Patients Undergoing One Anastomosis Gastric Bypass (OAGB): a Historical Cohort Study
  Authors: Abu-Zeid, E., Atias, S., Netz, U., Avital, I., Perry, Z.H.
  Journal: Obesity Surgery
  Year: 2024

EARLY ACADEMIC PURSUITS:

Marwa Muhammad Abu-Serie Ali initiated her academic journey in the field of biochemistry, obtaining a Bachelor's degree from Alexandria University, Egypt, with honors. She continued her academic pursuits with a Master's degree in Biochemistry from the same university in 2008. Later, in 2014, Marwa achieved a significant milestone by completing her Ph.D. in the Biochemistry Department at the Faculty of Science, Alexandria University, Egypt. Her doctoral thesis focused on a model for drug assessment of colon cancer induced in murine cells.

PROFESSIONAL ENDEAVORS:

Marwa's professional journey encompasses various roles, starting from a Delegated Demonstrator at Alexandria University to her current position as an Associate Professor in the Medical Biotechnology Department at the Genetic Engineering and Biotechnology Research Institute (GEBRI) in Egypt. She has consistently contributed to research and academia, progressing from Assistant Researcher to Researcher and eventually to her current leadership position as an Associate Professor.

CONTRIBUTIONS AND RESEARCH FOCUS ON TARGETED CANCER THERAPY

Marwa's research focus is on medical biotechnology, with specific interests in tageted cancer therapy studies. Her work includes projects such as the assessment of nanotherapeutic approaches in colon cancer, the development of anti-coronavirus agents, and the evaluation of novel anticancer agents. She has also explored the anti-tumor efficacy of various formulations against different types of carcinoma, emphasizing a comprehensive and innovative approach to cancer treatment.

IMPACT AND INFLUENCE:

Marwa has made significant contributions to the scientific community through her involvement in research projects funded by prestigious organizations like the Science & Technology Development Fund (STDF), Fulbright, and the Academy of Scientific Research and Technology Center (STC). Her work has not only expanded scientific knowledge but has also paved the way for potential breakthroughs in cancer treatment and the fight against infectious diseases.

LEGACY AND FUTURE CONTRIBUTIONS:

Marwa's legacy lies in her commitment to advancing knowledge in medical biotechnology, particularly in cancer research and antiviral drug development. Her future contributions are anticipated to further shape the landscape of biomedical research, potentially leading to breakthroughs in cancer treatment and viral therapeutics.